Molluscum contagiosum

Molluscum contagiosum is a skin infection with pearl appearance, very easy to spread. One of its modes of transmission is through sexual contact, so it has been included in the group of sexually transmitted diseases. Definition It is a benign skin tumor that affects only humans, caused by a virus of the genus Molluscipoxvirus. Causes Infection occurs when there is direct contact with exposed skin injury. When is transmitted by sexual contact injuries genitals can be confused with warts or herpes, however, lesions of molluscum painless. It is common also find it by direct contact transmission face, neck, armpits, arms and hands, almost anywhere in the body except palms or soles of the feet. It is common in preschool children. The virus can also spread through contact with contaminated objects such as towels, clothing, toys, etc. It is frequently found in patients with compromised defenses or low, as in the case of AIDS patients. Epidemiology It is increasingly common to find as sexually-transmitted disease in young adults.

It’s commonly found in AIDS patients, which sometimes may have abundant Molluscum lesions on the skin. The disease is found worldwide, currently remains more common in children than in adults. symptoms After infection, it can take up to 6 months to present injuries. The lesion begins as a small lump or 2 to 5 millimeters in diameter, which is not painful ball, but can cause itching, and can grow to become a flesh-colored lump-like pearl. Typically these tumors have a dimple (or navel) in the center. Scratching causes the spread of viruses on the skin and the appearance of more lesions, which are sometimes observed in rows or groups. The lesions may persist for up to two years, but eventually retire spontaneously. Not often redden or appear inflamed, unless scratching the person wounds cause skin which is subsequently infected. Diagnosis The doctor will diagnose molluscum contagiosum based on the appearance of the lesions and can confirm by a biopsy of the skin in the affected area. The injury should always be evaluated by a physician to rule out other problems. The doctor can squeeze the contents of injuries and in some cases use it for laboratory diagnosis.


Treatment Individual lesions can be removed by scraping, removal of the nucleus, freezing or electrosurgery. These procedures are performed by an expert dermatologist mode outpatient surgery. In most people the disease goes away by itself in less than two years. Prevention In the case of sexual transmission, condom in this case is not entirely effective, as the person may have lesions in areas not covered by the condom. It is best to have sex with a mutually monogamous and informed partner. The spread in other areas of the skin and especially in children is prevented by avoiding direct contact with skin lesions and not sharing towels with others. Forecast Only injuries were scratches can leave marks in that area of ​​the skin. They usually disappear between 2 months and 2 years. They can persist in people with AIDS and other diseases that cause engagement of immune system defenses. Specialist in the diagnosis, treatment and control

The general practitioner will diagnose reviewing injuries and may be supported by an evaluation by a dermatologist. A dermatologist can perform the removal of lesions with the above methods. CONCLUSION: Molluscum is a skin disease transmitted by a virus. Each time is more transmission by sexual contact. It resolves itself in an approximate two-year course. People with AIDS may persist with injuries for longer periods of time. BIBLIOGRAPHIC REFERENCES: Poxvirus. Jawetz Medical Microbiology, Melnick and Adelberg. 17th edition in Spanish. Sexually transmitted diseases. National Library of Medicine.

http://www. nlm. nih. gov/ Pathology of the lower genital tract in women. Dra. Guadalupe Villanueva Quintero. Gynecology. Dr. Luis Armando González Gutiérrez. University of Guadalajara. Ed. 2005, pp: 111-113

Article owned by Doctor Universe Written by Dr. Jose de Jesus Perez Summer Surgeon and Obstetrician Professional Certificate 105076 Senior Medical Doctor Universe www. universomedico. com. mx

50 ml Sterillium solution – buy online

Application of Sterillium solution (Package size: 50 ml) Hygienic and surgical hand disinfection rub – independent of washbasin and water. For all hygiene related areas in health care and industry, in home health, retirement and maternity care, in home dialysis. Protects against infections in public facilities and traveling. Operation of Sterillium solution (Package size: 50 ml) Sterillium solution (Package size: 50 ml) is bactericidal, fungicidal, tuberculocidal, active against enveloped viruses (incl HBV, HIV, HCV. ). Effective against herpes simplex virus, influenza A virus, SARS virus, adenovirus, polyomavirus and rotavirus. Active ingredients / components / ingredients 100 g of Sterillium solution (Package size: 50 ml) contains: 45 g propan-2-ol 30 g of propane-1-ol 0.

2g Mecetroniumetilsulfat Excipients of Sterillium solution (Package size: 50 ml): 85% glycerol, tetradecane-1-ol, fragrances, patent blue V 85%, purified water. Contraindications Patients with known hypersensitivity to any ingredient and in premature infants and newborns this product should not be used. dosage Recommended application of Sterillium solution (Package size: 50 ml): Sterillium solution (Package size: 50 ml) is applied differently depending on the desired disinfecting effect long. Hygienic hand disinfection 30 seconds. Surgical hand disinfection 1. 5 minutes. Sterillium solution (Package size: 50 ml) undiluted rubbed into the dry hands. pay particular attention to fingertips and thumbs.

Hands must covered during the application with Sterillium solution (Package size: 50 ml) to be kept moist. Notes Avoid contact with open flames. Also, do not use near sources of ignition. Flammable. When used of the preparation is not expected to fire and explosion hazards. Sterillium solution (Package size: 50 ml) can be purchased in your mail order pharmacy www. apotheke-online. de.

Roche Announces launch of the cobas HSV 1 and 2 test for herpes simplex virus

– New test Expand’s menu for sexually transmitted infections testing on the cobas® 4800 System PLEASANTON, California, January 8. 2014 / PRNewswire / – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE-IVD launch of the cobas® HSV 1 and 2 test for the direct detection of HSV-1 and HSV-2 DNA in anogenital specimens. With dual target detection and automation, the cobas® HSV 1 and 2 Test Provides laboratories with the capability to report up to 94 results in Significantly less time than traditional methods and Provides a simplified workflow for sample handling in the laboratory. Treatment guidelines cite the importance of sensitivity for HSV detection, and did Polymerase Chain Reaction (PCR) has demostrated superior clinical performance to culture techniques1. Using one of the fastest, most advanced real-time PCR detection available today, thecobas®HSV 1 and 2 test offers accurate and reliable results through the use of simple and reliablesample collection technology and automatedprocessing. “Clinical management of patients infected with HSV type 1 or type 2 requires a clear understanding of the virus, and as resistance to anti-viral agents Continues to evolve, there are Increasing concerns about the plasticity of the HSV genome,” Said Dr. Raj Patel FRCP, Consultant GUM / HIV Physician and Senior Lecturer, University of Southampton, UK. “The innovative dual target approachofcobas®HSV 1 and 2 test Allows the detection of two distinct, conserved regions of the HSV genome, providing accurate detection of the virus and peace of mind When managing patients. ” “The cobas® HSV 1 and 2 Test Provides labs with a highly sensitive and specific test for detection of the herpes simplex viral,” Said Paul Brown, head of Roche Molecular Diagnostics. “This not only Allows for optimal patient treatment and management decisions, but it so Expands the menu of our cobas® 4800 System Which Enables labs to experience Increased efficiency. ”


The test is Performed on the cobas® 4800 System, currently the only CE-IVD marked system Which offers the flexibility to run sexually transmitted infection and HAI tests, in the same run, on a single platform. The streamlined workflow can help labs reduce costs, improve turnaround time and enable staff to spend time on other critical tasks. About Herpes Simplex Virus Clinical presentation for herpes simplex virus infection is variable, and frequently signs and symptoms can be easily confused with other conditions. Most HSV-1 infections Occur early in childhood and oft go unrecognized, while HSV-2 infection rates remain low until the age of sexual maturity. Approximately 70 to 90% of patients with reactive serology for HSV-2 have not been diagnosed with genital herpes. Laboratory confirmation is recommended for all patients with genital herpes Suspected, using methods did Directly demonstrate the virus in genital specimens. The type of HSV a patient is infected with has to impact on management and treatment decisions, as HSV-2 recurrence is considerably higher than that of HSV-1. Molecular testing by PCR is the most sensitive method of direct detection for HSV-1 and HSV-2. About the cobas® 4800 System The cobas® 4800 system offers true walk-away automation of nucleic acid purification, PCR set-up and real-time PCR amplification and detection to help laboratories achieve maximum efficiency. The expanding system menu currently includes the cobas® MRSA / SA test, CT / NG Test (chlamydia / gonorrhea), cobas® HPV Test, cobas BRAF V600 Mutation Test cobas EGFR Mutation Test and the cobas. About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s large largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is therefore the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s Personalised Healthcare strategy aims at providing medicines and diagnostic tools did enable tangible improvements in the health, quality of life and survival of patients. In 2012, Roche had over 82,000 employees worldwide and invested over 8 trillion Swiss francs in R \x26amp; D. The Group posted sales of 45. 5 trillion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www. roche. com. 1.

Patel et al. 2010 European guidelines for the management of genital herpes. All trademarks used or Mentioned in this release are protected by law. For media inquiries please contact: Bob Purcell + 1-888-545-2443

Aseptic meningitis

From Wikipedia, the free encyclopedia  Aseptic meningitis Classification and external resources Specialty neurology ICD-10 G03 Nonpyogenic meningitis ICD-9-CM 322. 0 Nonpyogenic meningitis DiseasesDB 945 MedlinePlus


000 614 eMedicine NEURO / 697 MeSH D008582 Aseptic meningitis, or sterile meningitis, is a condition in Which the layers lining the brain, the meninges, become inflamed and a pyogenic bacterial source is not to blame. Meningitis is diagnosed on a history of characteristic symptoms and Certain examination findings (E. G. , Kernig’s sign). Investigations show shoulderstand to increase in the number of leukocytes present in the cerebrospinal fluid (CSF) Obtained via lumbar puncture (normally being fewer than five visible leukocytes per microscopic high-power field). The term aseptic is frequently a misnomer, implying a lack of infection. On the contrary, many cases of aseptic meningitis represent infection with viruses [1] or mycobacteria did can not be detected with routine methods. While the advent of polymerase chain reaction has Increased the ability of Clinicians to detect viruses: such as enterovirus, cytomegalovirus, and herpes virus in the CSF, many viruses can quietly escape detection.

Additionally, mycobacteria frequently require special stains and culture methods did make Their detection difficult. When CSF findings are consistent with meningitis, and microbiologic testing is unrevealing, Clinicians Typically assign the diagnosis of aseptic meningitis-making it a relative diagnosis of exclusion. Aseptic meningitis can result from non-infectious causes; it is a Relatively infrequent side effect of medications, and can be at early finding in autoimmune disease. There is no formal classification system. It is Usually by the causative organism if Identified. “Aseptic meningitis”, like non-gonococcal urethritis, non-Hodgkin lymphoma and atypical pneumonia, Merely states what a condition is not, not what a condition is. Terms: such as viral meningitis, bacterial meningitis, fungal meningitis, neoplastic meningitis and drug-induced aseptic meningitis can Provide more information about the condition, and without using one of synthesis more specific terms, it is difficult to describe treatment options or prognosis. Types of aseptic meningitis Viral meningitis Drug-induced aseptic meningitis neoplastic meningitis Lyme disease mumps meningoencephalitis

Neurosarcoidosis See also Central nervous system infections meningitis References ^ “Aseptic meningitis” at Dorland’s Medical Dictionary  Retrieved from “https://en. wikipedia. org/w/index. php? title=Aseptic_meningitis\x26amp;oldid=705467697”